Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Molecular Diagnosis & Therapy|December 27, 2023
Personalizing Oncolytic Immunovirotherapy ApproachesGeorgios M Stergiopoulos, Ianko Iankov, Evanthia GalanisFEMS Microbiology Letters|October 24, 2002
KN-62 enhances Chlamydia pneumoniae-induced p44/p42 mitogen-activated protein kinase activation in murine fibroblasts and attenuates in vitro infectionIana Haralambieva, Ianko Iankov, Vanio Mitev, et al.Journal of Immunological Methods|February 14, 2021
Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2Ianko Iankov, Kimberly Viker, Coleman Turgeon, et al.FEMS Microbiology Letters|September 3, 2003
Monoclonal antibody against O:5 Salmonella antigen cross-reacts with unidentified lipopolysaccharide epitope of Salmonella serogroup O:8 (C(2)-C(3))Ivan Mitov, Georgy Georgiev, Radka Ivanova, et al.Leukemia Research|February 13, 2002
The effect of chemical blockade of PKC with Gö6976 and Gö6983 on proliferation and MAPK activity in IL-6-dependent plasmacytoma cellsIanko Iankov, Maria Praskova, Silvia Kalenderova, et al.Diagnostic Microbiology and Infectious Disease|May 6, 2003
Cross-reactive monoclonal antibodies raised against the lipopolysaccharide antigen of Salmonella minnesota Re chemotype: diagnostic relevanceIvan Mitov, Iana Haralambieva, Dragomir Petrov, et al.Human Gene Therapy|December 22, 2011
Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS)Mateusz Opyrchal, Cory Allen, Ianko Iankov, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2007
Engineering oncolytic measles virus to circumvent the intracellular innate immune responseIana Haralambieva, Ianko Iankov, Kosei Hasegawa, et al.Cancer Research|February 12, 2009
Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptorYuqi Jing, Caili Tong, Jin Zhang, et al.Virus Research|December 17, 2025
Replication competent La Crosse virus pseudotyped VSV vector system as vaccine and serological diagnostic reagentIanko Iankov, Arun Ammayappan, Kimberly Viker, et al.Pageof 2